CHROMATIN, INC. DEMONSTRATES MINI-CHROMOSOME PERFORMANCE THROUGH 10 GENERATIONS
Medical News Today
Chromatin, Inc. presented their mini-chromosome research progress today at the American Seed Trade Association’s 63rd Annual Corn and Sorghum Seed Research Conference in Chicago.
The invited talk, entitled “Mini-chromosomes: The future of transgenic conversions” was presented by Shawn Carlson, Chromatin’s Director of Crop Genetics. Said Carlson, “This research, based on more than 10 generations of breeding, shows that mini-chromosomes are stable in hybrids and across a wide range of genetic backgrounds.”
Gregory P. Copenhaver, co-Founder and a member of Chromatin’s Board of Directors commented “presenting these results at one of the largest seed industry conventions allows Chromatin to showcase the benefits of gene stacking using mini-chromosomes.”
The company’s core Mini-chromosome technology allows rapid improvement of crops and feedstocks for agriculture and bioenergy markets, accelerating product pipelines, reducing production costs, and enabling novel plant-based products.
About Chromatin
Chromatin, Inc. develops and markets novel proprietary technology that enables entire chromosomes to be designed and incorporated into plant cells. These mini-chromosomes can be used in any plant to simultaneously introduce multiple genes while maintaining precise control of gene expression. Chromatin’s mini-chromosome technology can be used to deliver genes that benefit the agricultural, nutritional, energy, pharmaceutical, and chemical sectors.